Considering the above-discussed data, impairment of Akt signaling in MetS cardiomyocytes might be an adaptive mechanism in response to metabolic or oxidative disorders induced by sucrose consumption; however, further experiments are needed to confirm this hypothesis. The gene discussed is AKT1; the disease is metabolic syndrome.